Trial Profile
Lybrido(s)@home: a double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2021
Price :
$35
*
At a glance
- Drugs Buspirone/testosterone (Primary) ; Sildenafil/testosterone (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- Acronyms @HOME; AT-HOME
- Sponsors Emotional Brain
- 15 Mar 2012 Actual end date changed from 12 Feb 2009 to 15 Oct 2009 as reported by European Clinical Trials Database.
- 22 Oct 2009 New trial record